Page last updated: 2024-11-05

zolpidem and Dyskinesia, Drug-Induced

zolpidem has been researched along with Dyskinesia, Drug-Induced in 5 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research Excerpts

ExcerptRelevanceReference
"The use of zolpidem for antipsychotic-induced parkinsonian hand tremors in this patient was based on the severity of the symptoms and the lack of response to several trials of traditional medications."3.71Zolpidem for antipsychotic-induced parkinsonism. ( Farver, DK; Khan, MH, 2001)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waln, O1
Jankovic, J1
Echizenya, M1
Iwaki, S1
Suda, H1
Shimizu, T1
Bishnoi, M1
Chopra, K1
Kulkarni, SK1
Růzicka, E1
Roth, J1
Jech, R1
Busek, P1
Farver, DK1
Khan, MH1

Other Studies

5 other studies available for zolpidem and Dyskinesia, Drug-Induced

ArticleYear
Zolpidem improves tardive dyskinesia and akathisia.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:12

    Topics: Adult; Aged; Akathisia, Drug-Induced; Dyskinesia, Drug-Induced; Female; GABA-A Receptor Agonists; Hu

2013
Paradoxical reactions to hypnotic agents in adolescents with free-running disorder.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:3

    Topics: Adolescent; Anti-Anxiety Agents; Azepines; Dyskinesia, Drug-Induced; Female; Humans; Hypnotics and S

2009
Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jun-30, Volume: 31, Issue:5

    Topics: Animals; Anti-Dyskinesia Agents; Antioxidants; Antipsychotic Agents; Catalase; Chlorpromazine; Diaze

2007
Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:4

    Topics: Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; GABA Agonists;

2000
Zolpidem for antipsychotic-induced parkinsonism.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:4

    Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Hypnotics and Sedatives; Male; Psycho

2001